Stockhub

TRACON Pharmaceuticals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 August 2022

14 August 2022

10 August 2022

  • curprev 02:0002:00, 10 August 2022‎ 109.180.50.163 talk‎ 1,358 bytes +1,358‎ Created page with "TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/TRACON_Pharmaceuticals,_Inc.’